Gingko Bioworks to go public through $2.5B SPAC deal
Bio Pharma Dive
MAY 11, 2021
Bellco Capital, led by Kite Pharma and Allogene Therapeutics founder Arie Belldegrun, will co-sponsor the transaction alongside Eagle Equity Partners.
Bio Pharma Dive
MAY 11, 2021
Bellco Capital, led by Kite Pharma and Allogene Therapeutics founder Arie Belldegrun, will co-sponsor the transaction alongside Eagle Equity Partners.
World of DTC Marketing
MAY 11, 2021
IN SUMMARY: Hypertension, diabetes, and obesity drive a lot of healthcare costs, and the obesity epidemic may be one of the root causes of the rise in rates of hypertension, diabetes and even certain types of cancer. As the oldest millennials start to hit 40, many are finding themselves coping with chronic health conditions — more so than previous generations, according to some recent research and it’s going to lead to higher healthcare costs for ALL of us.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MAY 11, 2021
Rocket Pharma’s Danon disease treatment — key to the company's quiet rise over the past year — is the latest gene therapy to be put on hold by the agency. Executives predict only a short delay, however.
Pharma Mirror
MAY 11, 2021
I Holland, the world’s best-known manufacturer of tablet punches and dies for the pharmaceutical and nutraceutical industries, has announced it will be exhibiting some of it most innovative products at ACHEMA Pulse from 15-19 June, including the new die table segment cleaning equipment. The interactive platform will showcase the company’s extensive portfolio of precision tablet tooling solutions and services which have been developed during its 75 year history.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
MAY 11, 2021
The collaboration with Capsigen hands Biogen rights to a technology that could support the development of gene therapies for central nervous system and neuromuscular disorders.
pharmaphorum
MAY 11, 2021
Joined up thinking is the key to converting AI-driven advances into real benefits for healthcare systems, say NHSX. Healthcare systems the world over have been facing the same challenges for some time – and the pandemic has only served to compound them. Aging populations, a growing number of people living with long-term conditions, and dwindling resources meant the NHS was already being asked to do more with less before COVID-19 hit.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
MAY 11, 2021
Flagship Pioneering, the VC fund run by Moderna’s co-founder Noubar Afeyan has launched a new biotech Laronde , with an ambitious plan to create a new class of drugs based on Endless RNA. Called eRNA for short, this class of medicines is programmable and can continuously express therapeutic proteins inside the body. This makes the body into a “drug factory”, allowing for long-lasting medicines that allow for repeat redosing and can be administered easily by several routes.
Scienmag
MAY 11, 2021
Credit: Dorling Kindersley Anyone who’s raised a child or a pet will know just how fast and how steady their growth seems to be. You leave for a few days on a work trip and when you come home the child seems to have grown 10cm! That’s all well and good for the modern household, […].
XTalks
MAY 11, 2021
With CBD and THC infused beverages and edibles continuing to grow in popularity as more states legalize recreational cannabis, one company is hoping its technology will make these products safer for consumption. S?RSE Technology , a Seattle-based food emulsification company, is focusing its efforts on improving safety standards for CBD and THC infused foods and beverages, while ensuring a great-tasting and effective product.
Scienmag
MAY 11, 2021
Credit: Osaka University A group of researchers from Osaka University developed a quadruped robot platform that can reproduce the neuromuscular dynamics of animals (Figure 1), discovering that a steady gait and experimental behaviors of walking cats emerged from the reflex circuit in walking experiments on this robot. Their research results were published in Frontiers in […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioPharma Reporter
MAY 11, 2021
Charles River says the combination of Distributed Bioâs platform, which the CRO recently acquired, with its own downstream characterization capabilities, enables identification of the best lead candidate in CAR T cell therapies â balancing efficacy and safety for optimal therapeutic outcome.
Scienmag
MAY 11, 2021
First-of-its-kind in Singapore, the clinical trial will test a technology that enables specific cell therapy products to be manufactured for use in patients. Credit: Cordlife Group Limited SINGAPORE, 11 May 2021 – Institutes and centres under the SingHealth Duke-NUS Academic Medical Centre (AMC) are joining hands together with Singapore’s first private cord blood bank, Cordlife […].
BioSpace
MAY 11, 2021
Catch up on the investment news quickly with BioSpace's brief overview of the biotech companies hitting the Nasdaq and raking in fresh cash the past week.
Scienmag
MAY 11, 2021
The researchers have demonstrated that silencing or inhibiting the activity of these proteins completely reverses the aortic disease in a mouse model of Marfan Syndrome Credit: CNIC Scientists at the Centro Nacional de Investigaciones Cardiovasculares Centro de Biología Molecular Severo Ochoa (CBM-CSIC-UAM) have discovered that the nitric oxide (NO) pathway is overactivated in the aortas […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
MAY 11, 2021
First COVID-19 jab to be approved for emergency use in the US for this younger age group
Scienmag
MAY 11, 2021
Variation in how animals and bacteria use heme reveals potential target for new antibiotics Credit: (Courtesy of Robert Kranz) It took an unlikely food innovation — earth-friendly vegetarian patties, made to taste and “bleed” like the familiar meaty ones — to make people aware of heme. But heme is an essential part of proteins found […].
NY Times
MAY 11, 2021
The hope is that new treatments will encourage people to think of obesity as a chronic disease, like high blood pressure or diabetes.
BioSpace
MAY 11, 2021
In the U.S., many states and organizations are using unique tactics to improve vaccination rates including setting up mobile vans, offering $100 incentives, and free beers.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MAY 11, 2021
Study shows treatment developed by international team restored immune function in more than 95% of patients in three clinical trials Credit: Ann Johansson/UCLA Broad Stem Cell Research Center An experimental form of gene therapy developed by a team of researchers from UCLA and Great Ormond Street Hospital in London has successfully treated 48 of 50 […].
BioSpace
MAY 11, 2021
Please check out the biopharma industry's COVID-19 stories that are trending for May 11, 2021.
Scienmag
MAY 11, 2021
Credit: Gustavo Trindade Inks containing metal nanoparticles are among the most commonly-used conductive materials for printed electronics. Ink-jetting layers of MNP materials allows for unpreceded design flexibility, rapid processing and 3D printing of functional electronic devices such as sensors, solar panels, LED displays, transistors and smart textiles.
Pharma Times
MAY 11, 2021
Extension of indication expands access to drug for additional cystic fibrosis patients in Great Britain
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MAY 11, 2021
Algorithms must be tested and continually monitored to assess impact of bias Credit: Regenstrief Institute INDIANAPOLIS — Artificial intelligence (AI)-driven healthcare has the potential to transform medical decision-making and treatment, but these algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients.
BioSpace
MAY 11, 2021
The Series A rounds are the latest in a string of financing announcements made over the past few months.
Scienmag
MAY 11, 2021
Credit: University of Southampton A study by the University of Southampton has shown its LifeLab programme, aimed at improving adolescent health through hands-on learning, significantly increases young people’s understanding of what it means to lead a healthy lifestyle. Led by a team from both the Faculty of Medicine and Education School at the University of […].
Outsourcing Pharma
MAY 11, 2021
An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MAY 11, 2021
According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 per cent) of all deaths in the UK, which equates to more than 160,000 deaths each year – or one death every three minutes. The research, published in the top science journal Advanced Science, found that injection of the […].
BioSpace
MAY 11, 2021
Nearly 50 infants with "bubble baby" disease developed a working immune system after they received a gene therapy that contained the AIDS virus, according to a new study.
Scienmag
MAY 11, 2021
An international team of researchers at Great Ormond Street Hospital (GOSH), and University of California, Los Angeles (UCLA) have developed a gene therapy that successfully treated 48 out of 50 children with a form of severe combined immunodeficiency that leaves them without an immune system. Severe combined immunodeficiency due to adenosine deaminase deficiency, also known […].
BioSpace
MAY 11, 2021
Two new venture capital funds, Droia Ventures and Perceptive Advisors closed on new funds to invest in early-stage life science companies.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Let's personalize your content